Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals

J Immunol. 1987 Oct 1;139(7):2143-8.

Abstract

The relationship between induction of nuclear proto-oncogenes and cellular proliferation is not fully understood. To better define this relationship, we have studied c-fos, c-myc, and c-myb mRNA induction in T lymphocytes where early and late activation events have been clearly delineated. In T cells, initial activation from G0 to G1 results from stimulation of either the antigen/major histocompatibility complex receptor (T3-Ti) or the T11 structure; further cycle progression and proliferation follow interaction of interleukin 2 (IL-2) with the IL-2 receptor. These events can be dissected with monoclonal antibodies to T3 or T11 which cause early activation but differ in their ability to initiate IL-2-dependent cycle progression and proliferation. In T lymphocytes triggered through either T3-Ti or T11, c-fos is induced with a nonmitogenic activation signal whereas c-myb is only induced with a mitogenic signal capable of triggering IL-2 and IL-2 receptor expression. Furthermore, c-myc induction is biphasic and associated with both early and late activation events. Early c-myc, like c-fos, is induced with a nonmitogenic signal. In contrast, induction of late c-myc, like that of c-myb, requires a mitogenic signal. Thus, appearance of c-fos and initial c-myc mRNA seem to be early responses to membrane signaling whereas late c-myc and c-myb are more directly associated with actual cellular proliferation. That nonmitogenic stimulation of T cells via T3-Ti not only abrogates T11-mediated proliferation but also eliminates late c-myc and c-myb transcription further supports this notion.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigens, Surface / immunology*
  • CD3 Complex
  • Calcium / metabolism
  • Cell Division
  • Gene Expression Regulation
  • Humans
  • Interleukin-2 / pharmacology
  • Lymphocyte Activation*
  • Proto-Oncogene Proteins / biosynthesis*
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-myb
  • Proto-Oncogene Proteins c-myc
  • Proto-Oncogenes*
  • RNA, Messenger / biosynthesis
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism*
  • Tumor Necrosis Factor Receptor Superfamily, Member 7

Substances

  • Antigens, Surface
  • CD3 Complex
  • Interleukin-2
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-myb
  • Proto-Oncogene Proteins c-myc
  • RNA, Messenger
  • Tumor Necrosis Factor Receptor Superfamily, Member 7
  • Calcium